![Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2021-1288/asset/images/medium/figure3.gif)
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology
![Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-024-02153-6/MediaObjects/41375_2024_2153_Fig4_HTML.png)
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
![Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram](https://www.researchgate.net/publication/51664328/figure/fig4/AS:493081637199875@1494571231536/Proposed-treatment-algorithm-after-allergic-reactions-to-front-line-native-E-coli-ASE-on.png)
Proposed treatment algorithm after allergic reactions to front-line... | Download Scientific Diagram
![Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-024-02153-6/MediaObjects/41375_2024_2153_Fig2_HTML.png)
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
![Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram](https://www.researchgate.net/publication/368513863/figure/fig2/AS:1104479348887554@1640339805624/Bubble-plot-of-the-incidence-of-allergic-reactions-sum-of-allergies-and-allergic-like.png)
Bubble plot of the incidence of allergic reactions (sum of allergies... | Download Scientific Diagram
![A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia](https://jhoponline.com/images/jhop/june2014/pg45_table4.png)
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia
![Cancers | Free Full-Text | Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy Cancers | Free Full-Text | Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy](https://pub.mdpi-res.com/cancers/cancers-14-00902/article_deploy/html/images/cancers-14-00902-g001.png?1644585747)
Cancers | Free Full-Text | Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
![Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2021-1288/asset/images/medium/figure2.gif)
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation | Haematologica
![Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS](https://cjon.ons.org/sites/default/files/journal-images/Table1Huynh.png)
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
![Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018 Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018](https://journals.sagepub.com/cms/10.1177/1043454217741868/asset/images/large/10.1177_1043454217741868-fig1.jpeg)
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018
![Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804921012260-gr1.jpg)
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group - ScienceDirect
![Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram](https://www.researchgate.net/profile/Yves-Benoit-2/publication/293200044/figure/fig2/AS:530815080767488@1503567585632/Algorithm-for-treatment-with-PEG-asparaginase-mean-number-of-vials_Q320.jpg)
Algorithm for treatment with PEG-asparaginase (* = mean number of vials). | Download Scientific Diagram
![Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center | Scientific Reports Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-78549-y/MediaObjects/41598_2020_78549_Fig1_HTML.png)
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center | Scientific Reports
![Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1470204515003630-gr1.jpg)
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect
![How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia - ScienceDirect How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120621504-fx1ab.jpg)